Header cover image

Swedish (OMX) Biotech Industry Analysis

UpdatedMay 21, 2025
DataAggregated Company Financials
Companies60
  • 7D2.1%
  • 3M-9.7%
  • 1Y-2.1%
  • YTD-12.0%

The Biotech industry is up 1.4% in the last week, with Swedish Orphan Biovitrum up 3.0%. The industry has been flat over the past 12 months despite the gain this week. As for the next few years, earnings are expected to grow by 28% per annum.

Industry Valuation and Performance

Has the Swedish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 21 May 2025SEK 193.6bSEK 33.9bSEK 1.2b34.5x161.1x5.7x
Fri, 18 Apr 2025SEK 175.2bSEK 33.7bSEK 758.3m29x231.1x5.2x
Sun, 16 Mar 2025SEK 196.7bSEK 33.7bSEK 579.2m33.2x339.6x5.8x
Tue, 11 Feb 2025SEK 218.0bSEK 33.7bSEK 360.5m54.6x604.8x6.5x
Thu, 09 Jan 2025SEK 219.4bSEK 33.0b-SEK 4,418,647,416.22160.3x-49.6x6.6x
Sat, 07 Dec 2024SEK 214.0bSEK 33.0b-SEK 4,445,855,070.07146.4x-48.1x6.5x
Mon, 04 Nov 2024SEK 215.9bSEK 33.2b-SEK 4,482,059,813.14138.3x-48.2x6.5x
Wed, 02 Oct 2024SEK 210.4bSEK 31.4b-SEK 5,523,741,940.7849.5x-38.1x6.7x
Fri, 30 Aug 2024SEK 212.8bSEK 31.4b-SEK 5,507,219,147.5751x-38.6x6.8x
Sun, 28 Jul 2024SEK 205.1bSEK 31.4b-SEK 5,422,714,425.0246.9x-37.8x6.5x
Tue, 25 Jun 2024SEK 195.4bSEK 30.6b-SEK 5,516,807,975.1339.1x-35.4x6.4x
Thu, 23 May 2024SEK 190.8bSEK 30.6b-SEK 5,462,243,356.4039.4x-34.9x6.2x
Sat, 20 Apr 2024SEK 177.7bSEK 29.8b-SEK 5,266,079,807.9163.7x-33.8x6x
Mon, 18 Mar 2024SEK 186.1bSEK 29.8b-SEK 5,636,600,511.9959.6x-33x6.2x
Wed, 14 Feb 2024SEK 173.7bSEK 29.6b-SEK 5,690,161,945.7260.6x-30.5x5.9x
Fri, 12 Jan 2024SEK 187.1bSEK 28.7b-SEK 1,198,694,522.0058.8x-156.1x6.5x
Sun, 10 Dec 2023SEK 169.9bSEK 28.7b-SEK 1,200,221,950.0058.4x-141.6x5.9x
Tue, 07 Nov 2023SEK 157.8bSEK 28.6b-SEK 1,293,138,519.0048.4x-122x5.5x
Thu, 05 Oct 2023SEK 161.2bSEK 27.4b-SEK 2,017,277,396.0047.8x-79.9x5.9x
Sat, 02 Sep 2023SEK 155.3bSEK 27.4b-SEK 1,967,118,727.0052.5x-78.9x5.7x
Mon, 31 Jul 2023SEK 156.0bSEK 27.5b-SEK 1,534,283,427.0055.8x-101.7x5.7x
Wed, 28 Jun 2023SEK 160.4bSEK 26.4b-SEK 1,312,987,475.0045.5x-122.2x6.1x
Fri, 26 May 2023SEK 171.9bSEK 26.3b-SEK 1,366,671,495.0045.3x-125.8x6.5x
Sun, 23 Apr 2023SEK 173.8bSEK 25.5b-SEK 2,076,198,392.0039.7x-83.7x6.8x
Tue, 21 Mar 2023SEK 164.2bSEK 25.4b-SEK 2,030,181,364.0037.8x-80.9x6.5x
Thu, 16 Feb 2023SEK 176.3bSEK 25.3b-SEK 1,664,056,988.0027x-106x7x
Sat, 14 Jan 2023SEK 173.3bSEK 23.8b-SEK 1,844,394,225.0031.6x-94x7.3x
Mon, 12 Dec 2022SEK 157.5bSEK 23.8b-SEK 1,826,624,890.0032.1x-86.2x6.6x
Wed, 09 Nov 2022SEK 151.9bSEK 23.9b-SEK 3,186,214,696.0033x-47.7x6.4x
Fri, 07 Oct 2022SEK 155.4bSEK 22.9b-SEK 3,331,692,568.0032.1x-46.6x6.8x
Sun, 04 Sep 2022SEK 161.0bSEK 22.9b-SEK 3,245,057,861.0033.6x-49.6x7x
Tue, 02 Aug 2022SEK 173.8bSEK 22.7b-SEK 3,478,859,664.0035.8x-50x7.7x
Thu, 30 Jun 2022SEK 152.3bSEK 21.4b-SEK 3,520,100,841.0038.4x-43.3x7.1x
Sat, 28 May 2022SEK 157.9bSEK 21.4b-SEK 3,493,623,798.0044.3x-45.2x7.4x
Price to Earnings Ratio

-45.2x


Total Market Cap: SEK 157.9bTotal Earnings: -SEK 3,493,623,798.00Total Revenue: SEK 21.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Biotech Industry Price to Earnings3Y Average -48.3x202320242025
Current Industry PE
  • Investors are optimistic on the Swedish Biotechs industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 161x which is higher than its 3-year average PE of -48.5x.
  • The 3-year average PS ratio of 6.4x is higher than the industry's current PS ratio of 5.7x.
Past Earnings Growth
  • Total earnings for the Biotechs industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 17% per year.
  • This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market0.62%
Healthcare1.10%
Biotech2.11%
Biotech2.11%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SOBI Swedish Orphan BiovitrumSEK 310.403.0%
+SEK 3.1b
11.5%PE26.9x
BIOA B BioArcticSEK 185.007.6%
+SEK 1.2b
-17.0%PS63.6x
CRNO B Cereno ScientificSEK 10.7518.1%
+SEK 464.8m
183.6%PS37.4x
CURAS CurasightDKK 5.40157.1%
+DKK 69.8m
-46.0%PB45.6x
SANION SanionaSEK 8.395.9%
+SEK 64.0m
318.5%PE6.1x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

INIT

SEK 3.71

Initiator Pharma

7D

-40.7%

1Y

-59.8%

ACE

SEK 4.14

Ascelia Pharma

7D

6.4%

1Y

-58.6%

XINT

SEK 0.49

Xintela

7D

9.8%

1Y

96.8%

BINV

SEK 31.00

BioInvent International

7D

-5.9%

1Y

2.3%

HNSA

SEK 24.20

Hansa Biopharma

7D

-3.6%

1Y

-39.9%

CRNO B

SEK 10.75

Cereno Scientific

7D

18.1%

1Y

183.6%

DMYD B

SEK 9.52

Diamyd Medical

7D

4.5%

1Y

-19.6%

XSPRAY

SEK 30.30

Xspray Pharma

7D

-7.1%

1Y

-47.8%

SOBI

SEK 310.40

Swedish Orphan Biovitrum

7D

3.0%

1Y

11.5%

BONEX

SEK 280.60

Bonesupport Holding

7D

-0.4%

1Y

11.8%

EGTX

SEK 3.23

Egetis Therapeutics

7D

-11.5%

1Y

-57.0%

VITR

SEK 156.10

Vitrolife

7D

-1.8%

1Y

-15.9%

SANION

SEK 8.39

Saniona

7D

5.9%

1Y

318.5%